For the twelve months ended Sep 30, 2026, MetLife Inc. reported $82.56B of revenue and $5.13B of net income.
MET revenue was $20.52B in fiscal Q3 2026 (ended Sep 30, 2026), up 18.2% from a year earlier and up 7.1% from the prior quarter. For the full fiscal 2025 it was $77.08B, up 8.6% from fiscal 2024. Compound annual growth was +2.6% over 5 years and +2.3% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
MET net income was $2.40B in fiscal Q3 2026 (ended Sep 30, 2026), up 167.5% from a year earlier and up 225.7% from the prior quarter. For the full fiscal 2025 it was $3.38B, down 23.7% from fiscal 2024. Compound annual growth was -9.0% over 5 years and -4.5% over 10 years. It rose in 5 of the last 10 fiscal years.
MET diluted EPS was $3.67 in fiscal Q3 2026 (ended Sep 30, 2026), up 200.8% from a year earlier and up 236.7% from the prior quarter. For the full fiscal 2025 it was $4.71, down 20.7% from fiscal 2024. Compound annual growth was -3.7% over 5 years and +0.2% over 10 years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77.08B | $70.99B | $66.91B | $68.77B | $68.70B | $67.84B | $69.62B | $67.94B | $62.31B | $60.79B |
| Selling, general and admin | $560.00M | $481.00M | $828.00M | $669.00M | $670.00M | $761.00M | $901.00M | $910.00M | $1.13B | $1.01B |
| Operating income | $6.14B | $6.00B | $5.72B | $5.98B | - | - | - | - | - | - |
| Pre-tax income | $4.66B | $5.62B | $2.16B | $6.36B | $8.52B | $6.93B | $6.79B | $6.31B | $3.54B | $4.28B |
| Income tax | $1.26B | $1.18B | $560.00M | $1.06B | $1.64B | $1.51B | $886.00M | $1.18B | -$1.47B | $693.00M |
| Net income | $3.38B | $4.43B | $1.58B | $5.28B | $6.86B | $5.41B | $5.90B | $5.12B | $4.01B | $850.00M |
| EPS, basic | $4.74 | $5.98 | $1.82 | $6.35 | $7.71 | $5.72 | $6.10 | $4.95 | $3.65 | $0.68 |
| EPS, diluted | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 | $5.68 | $6.06 | $4.91 | $3.62 | $0.67 |
| Diluted shares | 673.3M | 711.1M | 762.3M | 808.9M | 869.4M | 913.2M | 944.4M | 1.01B | 1.08B | 1.11B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $22.03B | $20.07B | $20.64B | $20.20B | $20.05B | $19.80B | $16.60B | $15.82B | $12.70B | $12.65B |
| Short-term investments | $3.60B | $5.16B | $6.04B | $4.93B | $7.18B | $3.90B | $3.85B | $3.94B | $4.87B | $6.52B |
| Goodwill | $9.61B | $8.90B | $9.24B | $9.30B | $9.54B | $10.11B | $9.31B | $9.42B | $9.59B | $9.22B |
| Total assets | $745.17B | $677.46B | $687.58B | $663.07B | $759.71B | $795.15B | $740.46B | $687.54B | $719.89B | $898.76B |
| Short-term debt | $355.00M | $465.00M | $119.00M | $175.00M | $341.00M | $393.00M | $235.00M | $268.00M | $477.00M | $242.00M |
| Total debt | $14.47B | $15.09B | $15.55B | $14.65B | $13.93B | $14.60B | $13.47B | $12.83B | $15.69B | $16.44B |
| Total liabilities | $716.25B | $649.75B | $657.33B | $632.95B | $691.96B | $720.33B | $674.08B | $634.58B | $661.02B | $831.06B |
| Shareholders' equity | $28.40B | $27.70B | $30.25B | $30.13B | $50.01B | $74.82B | $66.38B | $52.96B | $58.87B | $67.70B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B | $11.64B | $13.79B | $11.74B | $12.28B | $14.77B |
| Investing cash flow | -$15.61B | -$11.49B | -$10.25B | -$2.62B | -$11.19B | -$18.57B | -$17.59B | -$5.63B | -$16.88B | -$5.85B |
| Financing cash flow | $163.00M | -$3.13B | -$2.94B | -$9.95B | -$1.13B | $10.73B | $4.57B | -$2.80B | -$906.00M | -$3.50B |
| Dividends paid | $1.51B | $1.53B | $1.57B | $1.60B | $1.65B | $1.66B | $1.64B | $1.68B | $1.72B | $1.74B |
| Share repurchases | $2.88B | $3.21B | $3.10B | $3.33B | $4.30B | $1.15B | $2.29B | $3.99B | $2.93B | $372.00M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 8.6% | 6.1% | -2.7% | 0.1% | 1.3% | -2.6% | 2.5% | 9.0% | 2.5% | -0.9% |
| Net income growth, YoY | -23.7% | 180.5% | -70.1% | -22.9% | 26.8% | -8.3% | 15.1% | 27.8% | 371.8% | -84.2% |
| EPS growth, YoY | -20.7% | 228.2% | -71.3% | -17.6% | 34.7% | -6.3% | 23.4% | 35.6% | 440.3% | -85.5% |
| Operating margin | 8.0% | 8.4% | 8.6% | 8.7% | - | - | - | - | - | - |
| Net margin | 4.4% | 6.2% | 2.4% | 7.7% | 10.0% | 8.0% | 8.5% | 7.5% | 6.4% | 1.4% |
| Return on equity | 11.9% | 16.0% | 5.2% | 17.5% | 13.7% | 7.2% | 8.9% | 9.7% | 6.8% | 1.3% |
| Return on assets | 0.5% | 0.7% | 0.2% | 0.8% | 0.9% | 0.7% | 0.8% | 0.7% | 0.6% | 0.1% |
| Debt to equity | 0.51 | 0.54 | 0.51 | 0.49 | 0.28 | 0.20 | 0.20 | 0.24 | 0.27 | 0.24 |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.52B | $19.15B | $19.07B | $23.81B | $17.36B | $17.34B | $18.57B | $18.67B | $18.44B | $17.82B | $16.06B | $19.03B |
| Selling, general and admin | $139.00M | $154.00M | $132.00M | $186.00M | $118.00M | $130.00M | $126.00M | $18.00M | $162.00M | $153.00M | $148.00M | $289.00M |
| Operating income | $1.83B | $1.60B | $1.63B | $1.68B | $1.65B | $1.39B | $1.42B | $1.49B | $1.44B | $1.66B | $1.40B | - |
| Pre-tax income | $3.00B | $1.03B | $1.51B | $1.12B | $1.21B | $980.00M | $1.35B | $1.38B | $1.99B | $1.20B | $1.04B | $941.00M |
| Income tax | $588.00M | $256.00M | $345.00M | $301.00M | $308.00M | $245.00M | $404.00M | $106.00M | $653.00M | $249.00M | $170.00M | $327.00M |
| Net income | $2.40B | $736.00M | $1.19B | $809.00M | $896.00M | $729.00M | $945.00M | $1.27B | $1.34B | $946.00M | $875.00M | $607.00M |
| EPS, basic | $3.70 | $1.10 | $1.75 | $1.18 | $1.23 | $1.04 | $1.29 | $1.77 | $1.82 | $1.28 | $1.11 | $0.78 |
| EPS, diluted | $3.67 | $1.09 | $1.74 | $1.18 | $1.22 | $1.03 | $1.28 | $1.75 | $1.81 | $1.28 | $1.10 | $0.77 |
| Diluted shares | 639.9M | 646.9M | 655.7M | - | 669.1M | 675.0M | 687.0M | - | 703.7M | 714.7M | 728.4M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $19.79B | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | $21.33B | $20.07B | $21.77B | $20.79B | $19.84B | $20.64B |
| Short-term investments | $7.88B | $8.02B | $4.95B | $3.60B | $5.96B | $5.30B | $5.54B | $5.16B | $4.61B | $3.80B | $4.88B | $6.04B |
| Goodwill | $9.54B | $9.54B | $9.56B | $9.61B | $9.10B | $9.14B | $9.04B | $8.90B | $9.15B | $8.95B | $9.04B | $9.24B |
| Total assets | $744.61B | $759.37B | $743.21B | $745.17B | $719.73B | $702.47B | $688.32B | $677.46B | $704.98B | $675.75B | $677.58B | $687.58B |
| Short-term debt | $289.00M | $460.00M | $404.00M | $355.00M | $378.00M | $379.00M | $381.00M | $465.00M | $404.00M | $390.00M | $127.00M | $119.00M |
| Total debt | $14.30B | $14.24B | $14.45B | $14.47B | $15.30B | $15.37B | $14.70B | $15.09B | $15.28B | $14.81B | $15.97B | $15.55B |
| Total liabilities | $721.89B | $731.41B | $715.41B | $716.25B | $690.53B | $674.54B | $660.56B | $649.75B | $673.81B | $648.21B | $648.78B | $657.33B |
| Shareholders' equity | $22.23B | $27.74B | $27.59B | $28.40B | $29.19B | $27.93B | $27.75B | $27.70B | $31.16B | $27.54B | $28.80B | $30.25B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.00B | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B | $4.17B | $3.49B | $2.33B | $5.18B |
| Investing cash flow | -$3.50B | -$8.87B | -$5.46B | -$4.29B | -$5.02B | -$2.98B | -$3.32B | -$5.36B | -$2.16B | -$1.34B | -$2.63B | $576.00M |
| Financing cash flow | $2.03B | $3.22B | $3.56B | -$998.00M | -$508.00M | $1.45B | $220.00M | -$519.00M | -$1.15B | -$1.21B | -$261.00M | -$176.00M |
| Dividends paid | $379.00M | $383.00M | $372.00M | $375.00M | $378.00M | $382.00M | $374.00M | $378.00M | $383.00M | $389.00M | $377.00M | $386.00M |
| Share repurchases | $651.00M | $722.00M | $755.00M | $460.00M | $502.00M | $510.00M | $1.41B | $406.00M | $774.00M | $855.00M | $1.17B | $859.00M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 18.2% | 10.5% | 2.7% | 27.6% | -5.9% | -2.7% | 15.6% | -1.9% | 16.2% | 7.2% | 4.3% | 21.9% |
| Net income growth, YoY | 167.5% | 1.0% | 25.4% | -36.3% | -33.2% | -22.9% | 8.0% | 109.4% | 174.4% | 135.3% | 929.4% | -61.5% |
| EPS growth, YoY | 200.8% | 5.8% | 35.9% | -32.6% | -32.6% | -19.5% | 16.4% | 127.3% | 223.2% | 166.7% | 5400.0% | -60.7% |
| Operating margin | 8.9% | 8.4% | 8.6% | 7.1% | 9.5% | 8.0% | 7.6% | 8.0% | 7.8% | 9.3% | 8.7% | - |
| Net margin | 11.7% | 3.8% | 6.2% | 3.4% | 5.2% | 4.2% | 5.1% | 6.8% | 7.3% | 5.3% | 5.4% | 3.2% |
| Debt to equity | 0.64 | 0.51 | 0.52 | 0.51 | 0.52 | 0.55 | 0.53 | 0.54 | 0.49 | 0.54 | 0.55 | 0.51 |
Source: XBRL data MetLife Inc. files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| MET | $82.56B | +14.8% | $5.13B | 6.2% | $62.45B |
| MFC | C$8.13B | +7.1% | C$5.57B | 68.5% | $71.43B |
| PRU | $61.33B | +6.5% | $3.88B | 6.3% | $40.90B |
| SLF | C$41.90B | +8.0% | C$3.55B | 8.5% | $39.70B |
| PUK | $11.49B | +7.0% | $3.98B | 34.6% | $30.94B |
| RGA | $27.32B | +22.5% | $1.71B | 6.3% | $17.10B |
| CRBG | $20.81B | +13.6% | $2.20B | 10.6% | $14.95B |
| AEG | - | - | €977.00M | - | $14.93B |
| GL | $6.27B | +5.6% | $1.19B | 18.9% | $11.86B |